LONN
Lonza is a leading contract development and manufacturing organization focused on the healthcare industry. Founded in Switzerland in 1897, it operates globally with about 19,000 employees across five continents and offers integrated biologics, small molecule, specialized modalities, and regulatory services to help pharmaceutical and biotech customers bring therapies to market. The company positions itself as a pioneer in the CDMO space with capabilities spanning mammalian biologics, small molecules, cell and gene therapy, and related manufacturing and development services. Lonza serves customers worldwide, delivering life-enhancing and life-saving treatments across diverse therapeutic areas.
No recent deals for this company.